Register entry

MC2 Therapeutics Ltd

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
3
Countries
0
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
10265265WYNZORAbetamethasone dipropionate; calcipotrieneproductSept 2027
11696919WYNZORAbetamethasone dipropionate; calcipotrieneproductMar 2039
12440499WYNZORAbetamethasone dipropionate; calcipotrieneproductMar 2039
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
WynzoraCalcipotriene and Betamethasone dipropionatecream, topical73499-001NDA
Enquiry

Common questions

Is MC2 Therapeutics Ltd FDA approved?
MC2 Therapeutics Ltd holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does MC2 Therapeutics Ltd make?
1 product is listed under MC2 Therapeutics Ltd in the openFDA NDC Directory, most often as cream. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.